Sesen bio, inc. (SESN)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Revenue:
Total revenue

0

0

425

29,981

-

-

-

-

Total revenue

-

-

-

-

490

2,243

1,334

-

License revenue

-

-

-

-

500

0

-

-

Other revenue

-

-

-

-

-

-

0

-

Total revenue

-

-

-

-

990

2,243

1,334

-

Operating expenses:
Research and development

24,663

14,077

12,510

13,479

26,336

26,703

13,788

15,263

General and administrative

12,208

11,623

8,070

14,736

9,850

8,471

4,024

4,213

Business Combination, Change in Fair Value of Contingent Consideration

71,620

8,800

9,100

-1,100

0

0

-

-

Total operating expenses

108,491

34,500

29,680

27,115

36,186

35,174

17,812

19,476

Income (Loss) from Operations

-108,491

-34,500

-29,255

2,866

-35,196

-32,931

-16,478

-19,476

Other income (expense):
Other income, net

991

807

226

-723

3,139

-849

-147

-13

Interest expense

-

-

-

-247

-1,395

-376

-1,400

-168

Total other income, net

-

-

-

-970

1,744

-1,225

-1,547

-181

Income (Loss) from Continuing Operations before Income Taxes, Domestic

-

-

-

1,896

-33,452

-34,156

-

-

Income Tax Expense (Benefit)

-

-

-

5

0

0

-

-

Net Income (Loss) and Comprehensive Income (Loss)

-107,500

-33,693

-29,029

1,891

-33,452

-34,156

-18,025

-19,657

Cumulative preferred stock dividends and accretion of preferred stock discount

-

-

-

-

-

519

3,857

3,111

Net income (loss) attributable to common stockholders - basic

-

-

-

-

-

-34,675

-21,882

-22,768

Net income (loss) per common share - basic (in dollars per share)

-

-

-

0.09

-1.76

-2.37

-

-

Weighted-average common shares outstanding - basic (in shares)

-

-

-

21,083

18,993

14,644

-

-

Net income (loss) per common share - diluted (in dollars per share)

-

-

-

0.09

-1.76

-2.37

-

-

Weighted-average common shares outstanding - diluted (in shares)

-

-

-

21,733

18,993

14,644

-

-

Net loss per common share - basic and diluted (in dollars per share)

-1.18

-0.55

-1.11

-

-

-

-16.18

-22.93

Weighted-average common shares outstanding - basic and diluted (in shares)

90,929

61,774

26,105

-

-

-

1,352

993

Collaboration revenue
Total revenue

-

-

-

406

-

-

-

-

License revenue
Total revenue

0

0

425

29,575

-

-

-

-